A observational, prospective, cohort study evaluating effect of belimumab on B cell and T cell alterations in systemic lupus erythematosus (SLE) patients.
Phase of Trial: Phase IV
Latest Information Update: 30 Jan 2017
At a glance
- Drugs Belimumab (Primary)
- Indications Systemic lupus erythematosus
- Focus Pharmacodynamics
- 30 Jan 2017 New trial record